137 related articles for article (PubMed ID: 15512980)
1. Antigen-presenting cells are targets of regulatory T cells similar to those that mediate anterior chamber-associated immune deviation.
Yokoi H; Streilein JW
Ocul Immunol Inflamm; 2004 Jun; 12(2):101-14. PubMed ID: 15512980
[TBL] [Abstract][Full Text] [Related]
2. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
[TBL] [Abstract][Full Text] [Related]
3. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
[TBL] [Abstract][Full Text] [Related]
4. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
[TBL] [Abstract][Full Text] [Related]
5. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
[TBL] [Abstract][Full Text] [Related]
6. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation.
Takeuchi M; Kosiewicz MM; Alard P; Streilein JW
Eur J Immunol; 1997 Jul; 27(7):1648-56. PubMed ID: 9247573
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.
Takeuchi M; Alard P; Streilein JW
J Immunol; 1998 Feb; 160(4):1589-97. PubMed ID: 9469414
[TBL] [Abstract][Full Text] [Related]
8. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
Hara Y; Okamoto S; Rouse B; Streilein JW
J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
[TBL] [Abstract][Full Text] [Related]
9. Critical contribution of CD80 and CD86 to induction of anterior chamber-associated immune deviation.
Tsukahara R; Takeuchi M; Akiba H; Kezuka T; Takeda K; Usui Y; Usui M; Yagita H; Okumura K
Int Immunol; 2005 May; 17(5):523-30. PubMed ID: 15778288
[TBL] [Abstract][Full Text] [Related]
10. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
Wilbanks GA; Mammolenti M; Streilein JW
Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
[TBL] [Abstract][Full Text] [Related]
11. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
12. Anterior chamber-associated immune deviation-inducing cells activate T cells, and rescue them from antigen-induced apoptosis.
Takeuchi M; Alard P; Verbik D; Ksander B; Streilein JW
Immunology; 1999 Dec; 98(4):576-83. PubMed ID: 10594691
[TBL] [Abstract][Full Text] [Related]
13. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
[TBL] [Abstract][Full Text] [Related]
14. Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells.
Kosiewicz MM; Streilein JW
J Immunol; 1996 Sep; 157(5):1905-12. PubMed ID: 8757308
[TBL] [Abstract][Full Text] [Related]
15. Effect of anterior chamber-associated immune deviation (ACAID) on rat islet allograft rejection.
Koevary SB; Beaudry K
Ocul Immunol Inflamm; 2000 Mar; 8(1):39-47. PubMed ID: 10806433
[TBL] [Abstract][Full Text] [Related]
16. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen.
Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347
[TBL] [Abstract][Full Text] [Related]
17. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
D'Orazio TJ; Niederkorn JY
J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
[TBL] [Abstract][Full Text] [Related]
18. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta.
Wilbanks GA; Streilein JW
Eur J Immunol; 1992 Apr; 22(4):1031-6. PubMed ID: 1551403
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
Kosiewicz MM; Alard P; Liang S; Clark SL
Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
